Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Dear Visitor: Equitymaster will be under maintenance from 10:00AM to 11.30AM on Sunday, 25 March 2018. During this period, our websites will be accessible though there is a possibility of some intermittent accessibility issues. Please bear with us. We are taking yet another step to make browsing Equitymaster a much faster experience! Thank you.

Revenue growth set to slow considerably
Thu, 28 Jun Pre-Open

High interest costs and high commodity prices are wrecking India Inc's profit margins. But the bottom line of companies may not be the only thing in trouble. According to leading rating agency Crisil, leading corporates are expected to show their weakest sales growth numbers in six quarters. Revenue growth in the first quarter of the new fiscal year is forecast to drop to around 14% from 17.5% earlier, given the economic slowdown and a fall in investments. Accordingly, operating margins are also expected to drop 1-1.5% to around 19-20%.

A number of sectors are seeing multiple negative headwinds. There have been a number of structural problems as well as demand deceleration in airlines, auto components, hotels, metals, and real estate companies. According to the rating agency, for certain sectors such as cement, construction and real estate margins are expected to contract by 1-2% on slower demand and high input costs. But the rupee depreciation may have a silver lining for export oriented companies in the IT and pharma space. These sectors may see significant margin expansion on this count.

The important question is as to how things will pan out going forward. Well, interest rates are still expected to remain elevated. To the surprise of the industry, the Reserve Bank of India (RBI) decided to maintain status quo in its latest policy review. This was despite GDP growth in FY12 reaching a 9 year low. Policy inaction and the souring of the investment cycle are also expected to keep things difficult. Persistent inflation and economic uncertainty both domestically as well as overseas are also expected to add to the pressure.

There seems to be no concrete resolution to the European debt crisis and even the US seems to be struggling. All these factors are weighing in on consumer sentiment, thereby affecting consumption growth and consequently sales growth of companies. And with these problems expected to persist for the next few quarters, we don't really expect much of a recovery in FY13. It will take some time for these issues to sort themselves out.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Revenue growth set to slow considerably". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Mar 23, 2018 (Close)